NCT06576635 2026-01-20
LUNG-05
University of Illinois at Chicago
Phase NA Recruiting
Clinical Trials
11 trialsNCT07247227 2025-11-25
Real-world First-line Sugemalimab-Chemotherapy in Advanced NSCLC
Peking Union Medical College
Phase NA Recruiting
NCT06457789 2025-04-02
iRelate
Amsterdam UMC, location VUmc
Phase NA Recruiting
NCT02869685 2024-02-23
RadImm02
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT02890849 2024-02-23
RadImm01
Xinqiao Hospital of Chongqing
Phase NA Completed
NCT05999214 2023-09-25
99mTc-H7ND SPECT/CT Imaging in NSCLC
First Affiliated Hospital Xi'an Jiaotong University
Phase NA Recruiting
NCT04720339 2022-11-23
Molecular Monitoring of cfDNA by ddPCR in Non-small Cell Lung Cancer Treated by Immunotherapy.
University Hospital, Strasbourg, France
Phase NA Recruiting
NCT02354274 2022-04-25
Novel Approach to Radiotherapy in Locally Advanced Lung Cancer Concomitant NavelbineĀ®
Odense University Hospital
Phase NA Recruiting
NCT04007835 2019-07-05
Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI
Guangdong Association of Clinical Trials
Phase NA Unknown
NCT03606070 2019-01-04
IMAHTEP
Gustave Roussy, Cancer Campus, Grand Paris
Phase NA Unknown
NCT02315053 2017-10-27
PET Response During Chemoradiation of Lung Cancer
The Netherlands Cancer Institute
Phase NA Completed